Fei-Ting Hsu Selected Research

hyperforin

10/2020	Hyperforin induces apoptosis through extrinsic/intrinsic pathways and inhibits EGFR/ERK/NF-κB-mediated anti-apoptotic potential in glioblastoma.
11/2019	Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer.
1/2018	Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fei-Ting Hsu Research Topics

Disease

48	Neoplasms (Cancer) 03/2022 - 03/2012
29	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 07/2012
14	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 11/2017
10	Neoplasm Metastasis (Metastasis) 05/2022 - 09/2018
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2018
7	Body Weight (Weight, Body) 01/2021 - 01/2018
5	Osteosarcoma (Osteogenic Sarcoma) 05/2022 - 06/2019
4	Squamous Cell Carcinoma of Head and Neck 03/2022 - 04/2014
4	Urinary Bladder Neoplasms (Bladder Cancer) 11/2019 - 01/2017
4	Leukemia 06/2019 - 03/2018
3	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 05/2020
3	Carcinoma (Carcinomatosis) 01/2017 - 09/2014
2	Brain Neoplasms (Brain Tumor) 12/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 05/2018 - 02/2016
2	Glioma (Gliomas) 01/2018 - 01/2018
1	Chronic Hepatitis C 01/2022
1	Schizophrenia (Dementia Praecox) 01/2022
1	Adenocarcinoma 01/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Colonic Neoplasms (Colon Cancer) 04/2021
1	Melanoma (Melanoma, Malignant) 04/2021
1	Depressive Disorder (Melancholia) 10/2020

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2015
13	Sorafenib (BAY 43-9006)FDA Link 05/2022 - 07/2012
13	regorafenibIBA 03/2022 - 01/2017
12	amentoflavoneIBA 05/2022 - 09/2017
12	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022 - 01/2018
9	NF-kappa B (NF-kB)IBA 01/2022 - 07/2012
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 07/2012
7	magnololIBA 12/2021 - 11/2018
6	Pharmaceutical PreparationsIBA 01/2022 - 02/2016
6	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2022 - 09/2018
5	Apoptosis Regulatory ProteinsIBA 03/2021 - 01/2018
4	lenvatinibIBA 05/2022 - 01/2021
4	Metalloproteases (Metalloproteinases)IBA 01/2022 - 06/2019
4	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 11/2021 - 09/2018
4	Phosphotransferases (Kinase)IBA 06/2021 - 06/2019
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 11/2016
4	ErbB Receptors (EGF Receptor)IBA 10/2020 - 11/2017
4	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2020 - 06/2019
4	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2020 - 05/2018
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 06/2020
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 08/2019
3	CurcuminIBA 05/2021 - 04/2014
3	Matrix Metalloproteinases (MMPs)IBA 10/2020 - 06/2019
3	hyperforinIBA 10/2020 - 01/2018
3	Fluoxetine (Prozac)FDA LinkGeneric 06/2020 - 09/2018
3	EnzymesIBA 06/2019 - 03/2018
3	Protein CIBA 06/2019 - 03/2018
2	Biological ProductsIBA 01/2022 - 09/2018
2	Caspase 3 (Caspase-3)IBA 01/2022 - 03/2018
2	Quetiapine Fumarate (Seroquel)FDA Link 01/2022 - 09/2020
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2020
2	AlbuminsIBA 01/2022 - 04/2021
2	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2022 - 01/2020
2	Interleukin-15 (Interleukin 15)IBA 01/2022 - 04/2021
2	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 09/2020
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 11/2021
2	SolutionsIBA 11/2021 - 05/2021
2	Phosphates (Orthophosphate)IBA 11/2021 - 05/2021
2	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 12/2020
2	Imipramine (Janimine)FDA LinkGeneric 01/2021 - 01/2020
2	Radiation-Sensitizing AgentsIBA 07/2020 - 11/2014
2	BromidesIBA 01/2020 - 11/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2019 - 12/2016
2	thiazolyl blueIBA 06/2019 - 05/2018
2	LuciferasesIBA 09/2018 - 01/2018
2	ferric oxide (iron oxide)IBA 01/2018 - 11/2017
1	antiglomerular basement membrane antibodyIBA 01/2022
1	bisdemethoxycurcuminIBA 01/2022
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2022
1	Protein Kinase C-deltaIBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Albumin-Bound Paclitaxel FDA Link 01/2022
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 01/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2021
1	tetrandrineIBA 11/2021
1	Oxygen (Dioxygen)IBA 10/2021
1	Pemetrexed (MTA)FDA Link 09/2021
1	demethoxycurcuminIBA 05/2021
1	human IL15 proteinIBA 04/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2020
1	Protective AgentsIBA 09/2020
1	Epidermal Growth Factor (EGF)IBA 08/2020
1	Antidepressive Agents (Antidepressants)IBA 06/2020
1	Biphenyl CompoundsIBA 05/2020
1	astragaloside AIBA 03/2020
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2020
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2020
1	Coloring Agents (Dyes)IBA 08/2019

Therapy/Procedure

7	Therapeutics 03/2022 - 02/2016
6	Drug Therapy (Chemotherapy) 01/2022 - 03/2012
6	Radiotherapy 11/2020 - 03/2012
3	Aftercare (After-Treatment) 11/2021 - 09/2018
2	Immunotherapy 03/2022 - 04/2021
2	Precision Medicine 01/2018 - 11/2016
1	Intraperitoneal Injections 01/2020